Table 1. The effects of STAT3-KD and rescue with WT-STAT3 on gene expression in GBMX16 GICs.
Neuro Panel | ||||
---|---|---|---|---|
Gene | Alias | STAT3 KDa | Rescueb | Function |
Fold Change | ||||
AMIGO | ALI2, AMIGO-1 | 1.58 ⇓ | 1.16 ⇑ | Myelination |
ARRB2 | ARB2, ARR2 | 1.31 ⇓ | 1.33 ⇑ | Neural Structure, Signaling |
ANG | ALS9, RNASE4 | 3.51 ⇓ | 1.28 ⇑ | Angiogenesis |
DRD2 | D2DR, D2R | 2.42 ⇓ | 6.67 ⇑ | Transmitter release |
GATA2 | DCML, IMD21 | 58.06 ⇓ | 46.9 ⇑ | Angiogenesis, Chromatin Modification |
CDS1 | CDS | 12.34 ⇑ | 3.3 ⇓ | Metabolism, Signaling |
CHD4 | Mi-2b, Mi2-beta | 1.51 ⇑ | 3.1 ⇓ | Chromatin Modification |
Immune Panel | ||||
---|---|---|---|---|
Gene | Alias | STAT3 KD | Rescue | Function |
Fold Change | ||||
PBK | SPK, CT84 | 3.54 ⇓ | 2.06 ⇑ | Tumorigenesis |
S100B | NEF | 1.36 ⇓ | 1.9 ⇑ | Cell Cycle |
THY1 | CD90 | 3.5 ⇓ | 2 ⇑ | Adhesion |
HMGB1 | SBP-1 | 2.15 ⇓ | 1.68 ⇑ | Metastasis |
CDK1 | CDC2 | 2.51 ⇓ | 1.07 ⇑ | Cell Cycle |
HLADPB1 | DPB1 | 1.25 ⇓ | 4.4 ⇑ | Immunity |
CD200 | OX-2, MOX1 | 7.2 ⇓ | 3.74 ⇑ | Immune suppression |
CCL2 | MCAF, MCP1 | 13.7 ⇓ | 6.25 ⇑ | Inflammation and Immune regulation |
Cancer Panel | ||||
---|---|---|---|---|
Gene | Alias | STAT3 KD | Rescue | Function |
Fold Change | ||||
BTG1 | APRO2 | 2.92 ⇑ | 5.91 ⇓ | Anti-tumorigenic |
COL6A1 | OPLL, BTHLM1 | 6.54 ⇑ | 4.5 ⇓ | Adhesion |
PMP22 | CIDP, CMT1A | 1.82 ⇑ | 2.7 ⇓ | Anti-proliferative |
HIF1A | HIF1-alpha | 1.46 ⇑ | 2.63 ⇓ | Metabolism, Apoptosis, Angiogenesis |
a Fold change = gene expression in control GBMX16/STAT3-KD.
b Fold change = gene expression in WT-STAT3 rescue/STAT3-KD.